e-learning
resources
Barcelona 2010
Saturday, 18.09.2010
PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How to manage side-effects of targeted therapies?
D. Moro Sibilot (Grenoble, France)
Source:
Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Session:
PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Session type:
Postgraduate Course
Number:
64
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Moro Sibilot (Grenoble, France). How to manage side-effects of targeted therapies?. Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
How to manage side-effects of radiotherapy?
Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Year: 2010
How to optimise the efficacy of pharmacological treatments?
Source: Annual Congress 2011 - New advances in smoking cessation
Year: 2011
How to manage haematological complications of chemotherapy?
Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Year: 2010
More hope for cure by individualised adjuvant treatment?
Source: Annual Congress 2010 - Customised chemotherapy for lung cancer
Year: 2010
Which therapeutic options when CPAP fails?
Source: ERS Course 2017 - Paediatric noninvasive ventilation
Year: 2017
How to manage surgical complications?
Source: Annual Congress 2010 - PG7 Postgraduate Course: How to manage treatment complications of lung cancer
Year: 2010
What could we learn from ongoing therapeutic trials?
Source: ERS Research Seminar
Year: 2015
Multidimensional approaches to asthma: the need to look beyond drug treatments
Source: Annual Congress 2010 - Breathing therapies for asthma
Year: 2010
Which kind of acute patients can pulmonology safely treat?
Source: Annual Congress 2011 - Pulmonologists and intensivists: two hearts are better than one?
Year: 2011
Lots of promising targets and biomarkers, but how can we deliver the next generation of severe asthma trials?
Source: International Congress 2019 – Beyond T2 mechanisms in asthma: who are the other players?
Year: 2019
Systemic therapies: optimising the sequences of chemotherapies, targeted therapies and immunotherapies
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Who should receive which biologic and why? Current and future approaches in severe asthma patients
Source: Virtual Congress 2021 – Linking scientific mechanisms to recent clinical therapeutic advances in airway disease: why, who, when and what?
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept